Drug Trial Radar · NCT01214850
Novartis Vaccine and Diagnostics Carriage Trial
Last checked: Nov 19, 2026Latest source record: Apr 21, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,968
Actual
Start
Sep 2010
Primary completion
Jan 2012
Study completion Jan 2012
Sponsor
- Lead sponsor
- Novartis VaccinesNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Oct 5, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 24 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this trial was to evaluate the effect of Novartis Vaccine's Meningococcal vaccines on carriage of Neisseria meningitidis in a young adult population.
Conditions
- N. Meningitidis Carriage
Interventions
Meningococcal B Recombinant + Outer Membrane Vesicle vaccine (rMenB+OMV NZ)Biological
MenACWY-CRM conjugate vaccineBiological
Japanese Encephalitis vaccineBiological
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentages of Subjects With Carriage of Virulent Sequence Types (ST) of Neisseria Meningitidis Group B, One Month After Completion of rMenB+OMV NZ VaccinationTime frame: 61 days (31 days after receiving the second injection)
- Percentages of Subjects With Combined Carriage of N. Meningitidis Serogroups A, C, W and Y, One Month After MenACWY-CRM VaccinationTime frame: 31 days after MenACWY-CRM injection
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Bristol Children's Vaccine Center, University of Bristol,
Bristol, England, United Kingdom
Royal Liverpool and Broad Green University Hospital Trust
Liverpool, England, United Kingdom
St Georges Vaccine Institute, St Georges, University of London
London, England, United Kingdom
Manchester Welcome Trust Clinical Research Facility, University of Manchester
Manchester, England, United Kingdom
The James Cook University Hospital
Middlesbrough, England, United Kingdom
Cripps Health Centre, University Park
Nottingham, England, United Kingdom
University of Oxford, Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine
Oxford, England, United Kingdom
Clinical Research Facility, Royal Hallamshire Hospital
Sheffield, England, United Kingdom
Wellcome Trust Clinical Research Facility, University of Southampton
Southampton, England, United Kingdom
Clinical Research Center, University of Surrey
Surrey, England, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.